Copyright Reports & Markets. All rights reserved.

Global Colorectal Cancer Therapeutics Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Colorectal Cancer Therapeutics

      • 1.1 Definition of Colorectal Cancer Therapeutics
      • 1.2 Colorectal Cancer Therapeutics Segment by Type
        • 1.2.1 Global Colorectal Cancer Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Diagnostics
        • 1.2.3 Therapeutics
      • 1.3 Colorectal Cancer Therapeutics Segment by Applications
        • 1.3.1 Global Colorectal Cancer Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinic
        • 1.3.4 Research institutions
      • 1.4 Global Colorectal Cancer Therapeutics Overall Market
        • 1.4.1 Global Colorectal Cancer Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Colorectal Cancer Therapeutics Production (2014-2025)
        • 1.4.3 North America Colorectal Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Colorectal Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Colorectal Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Colorectal Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Colorectal Cancer Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Colorectal Cancer Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Colorectal Cancer Therapeutics
      • 2.3 Manufacturing Process Analysis of Colorectal Cancer Therapeutics
      • 2.4 Industry Chain Structure of Colorectal Cancer Therapeutics

      3 Development and Manufacturing Plants Analysis of Colorectal Cancer Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Colorectal Cancer Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Colorectal Cancer Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Colorectal Cancer Therapeutics Production and Capacity Analysis
      • 4.2 Colorectal Cancer Therapeutics Revenue Analysis
      • 4.3 Colorectal Cancer Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Colorectal Cancer Therapeutics Regional Market Analysis

      • 5.1 Colorectal Cancer Therapeutics Production by Regions
        • 5.1.1 Global Colorectal Cancer Therapeutics Production by Regions
        • 5.1.2 Global Colorectal Cancer Therapeutics Revenue by Regions
      • 5.2 Colorectal Cancer Therapeutics Consumption by Regions
      • 5.3 North America Colorectal Cancer Therapeutics Market Analysis
        • 5.3.1 North America Colorectal Cancer Therapeutics Production
        • 5.3.2 North America Colorectal Cancer Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Colorectal Cancer Therapeutics Import and Export
      • 5.4 Europe Colorectal Cancer Therapeutics Market Analysis
        • 5.4.1 Europe Colorectal Cancer Therapeutics Production
        • 5.4.2 Europe Colorectal Cancer Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Colorectal Cancer Therapeutics Import and Export
      • 5.5 China Colorectal Cancer Therapeutics Market Analysis
        • 5.5.1 China Colorectal Cancer Therapeutics Production
        • 5.5.2 China Colorectal Cancer Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Colorectal Cancer Therapeutics Import and Export
      • 5.6 Japan Colorectal Cancer Therapeutics Market Analysis
        • 5.6.1 Japan Colorectal Cancer Therapeutics Production
        • 5.6.2 Japan Colorectal Cancer Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Colorectal Cancer Therapeutics Import and Export
      • 5.7 Southeast Asia Colorectal Cancer Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Colorectal Cancer Therapeutics Production
        • 5.7.2 Southeast Asia Colorectal Cancer Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Colorectal Cancer Therapeutics Import and Export
      • 5.8 India Colorectal Cancer Therapeutics Market Analysis
        • 5.8.1 India Colorectal Cancer Therapeutics Production
        • 5.8.2 India Colorectal Cancer Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Colorectal Cancer Therapeutics Import and Export

      6 Colorectal Cancer Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Colorectal Cancer Therapeutics Production by Type
      • 6.2 Global Colorectal Cancer Therapeutics Revenue by Type
      • 6.3 Colorectal Cancer Therapeutics Price by Type

      7 Colorectal Cancer Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Colorectal Cancer Therapeutics Consumption by Application
      • 7.2 Global Colorectal Cancer Therapeutics Consumption Market Share by Application (2014-2019)

      8 Colorectal Cancer Therapeutics Major Manufacturers Analysis

      • 8.1 Taiho Pharma
        • 8.1.1 Taiho Pharma Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.1.2 Taiho Pharma Product Introduction, Application and Specification
        • 8.1.3 Taiho Pharma Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Merck KGaA
        • 8.2.1 Merck KGaA Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.2.2 Merck KGaA Product Introduction, Application and Specification
        • 8.2.3 Merck KGaA Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Amgen
        • 8.3.1 Amgen Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.3.2 Amgen Product Introduction, Application and Specification
        • 8.3.3 Amgen Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Takeda
        • 8.4.1 Takeda Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.4.2 Takeda Product Introduction, Application and Specification
        • 8.4.3 Takeda Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Roche
        • 8.5.1 Roche Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.5.2 Roche Product Introduction, Application and Specification
        • 8.5.3 Roche Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eli Lilly
        • 8.6.1 Eli Lilly Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.6.2 Eli Lilly Product Introduction, Application and Specification
        • 8.6.3 Eli Lilly Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Regeneron
        • 8.8.1 Regeneron Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.8.2 Regeneron Product Introduction, Application and Specification
        • 8.8.3 Regeneron Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Bayer
        • 8.9.1 Bayer Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.9.2 Bayer Product Introduction, Application and Specification
        • 8.9.3 Bayer Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Onyx
        • 8.10.1 Onyx Colorectal Cancer Therapeutics Production Sites and Area Served
        • 8.10.2 Onyx Product Introduction, Application and Specification
        • 8.10.3 Onyx Colorectal Cancer Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Bristol-Myers Squib
      • 8.12 Sumitomo Dainippon Pharma
      • 8.13 Array BioPharma
      • 8.14 Hutchison MediPharma
      • 8.15 Jiangsu Hengrui Medicine
      • 8.16 Jiangsu Chia-Tai Tianqing
      • 8.17 Suzhou Zelgen Biopharmaceuticals

      9 Development Trend of Analysis of Colorectal Cancer Therapeutics Market

      • 9.1 Global Colorectal Cancer Therapeutics Market Trend Analysis
        • 9.1.1 Global Colorectal Cancer Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Colorectal Cancer Therapeutics Regional Market Trend
        • 9.2.1 North America Colorectal Cancer Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Colorectal Cancer Therapeutics Forecast 2019-2025
        • 9.2.3 China Colorectal Cancer Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Colorectal Cancer Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Colorectal Cancer Therapeutics Forecast 2019-2025
        • 9.2.6 India Colorectal Cancer Therapeutics Forecast 2019-2025
      • 9.3 Colorectal Cancer Therapeutics Market Trend (Product Type)
      • 9.4 Colorectal Cancer Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Colorectal Cancer Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

        The global Colorectal Cancer Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Colorectal Cancer Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colorectal Cancer Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Colorectal Cancer Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Colorectal Cancer Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Taiho Pharma
        Merck KGaA
        Amgen
        Takeda
        Roche
        Eli Lilly
        Sanofi
        Regeneron
        Bayer
        Onyx
        Bristol-Myers Squib
        Sumitomo Dainippon Pharma
        Array BioPharma
        Hutchison MediPharma
        Jiangsu Hengrui Medicine
        Jiangsu Chia-Tai Tianqing
        Suzhou Zelgen Biopharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Diagnostics
        Therapeutics

        Segment by Application
        Hospitals
        Clinic
        Research institutions

        Buy now